(12-105) Adverse Reactions Associated with High-Dose Fentanyl as the Primary Opioid Agent for Analgosedation in Critically Ill Medical Patients

Wednesday, December 7, 2022

2:00 PM – 3:00 PM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Critical Care

Co-Author(s): Elizabeth Gau, Megan Moore

Primary Author(s)

Jennifer Spadgenske, Pharm D
Pharmacy Resident
Sanford Health Medical Center Fargo, North Dakota